50 mg LX3305 QD
LX3305.1-106-RA
Phase 1 small_molecule completed
Quick answer
50 mg LX3305 QD for Rheumatoid Arthritis is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed